| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 948.82B | 958.51B | 886.52B | 819.17B | 736.04B |
| Gross Profit | 229.98B | 231.47B | 210.56B | 191.40B | 171.84B |
| EBITDA | 95.77B | 91.57B | 97.06B | 89.90B | 82.07B |
| Net Income | 46.79B | 53.83B | 51.59B | 48.97B | 44.14B |
Balance Sheet | |||||
| Total Assets | 496.08B | 493.89B | 436.55B | 418.81B | 394.39B |
| Cash, Cash Equivalents and Short-Term Investments | 28.64B | 36.51B | 40.67B | 47.43B | 42.82B |
| Total Debt | 156.76B | 79.73B | 75.25B | 73.35B | 64.69B |
| Total Liabilities | 260.12B | 261.02B | 237.46B | 216.34B | 208.51B |
| Stockholders Equity | 235.96B | 232.88B | 199.09B | 202.47B | 185.88B |
Cash Flow | |||||
| Free Cash Flow | 41.76B | 37.87B | 56.33B | 43.17B | 44.42B |
| Operating Cash Flow | 78.32B | 72.64B | 85.12B | 64.47B | 64.88B |
| Investing Cash Flow | -35.31B | -30.53B | -29.76B | -20.32B | -19.13B |
| Financing Cash Flow | -47.84B | -49.80B | -58.55B | -39.64B | -37.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $447.32B | 49.15 | 30.32% | 0.59% | 8.34% | 9.58% | |
73 Outperform | $1.02T | 43.44 | 22.97% | 0.85% | 4.34% | 17.27% | |
73 Outperform | $33.69B | 19.21 | 16.45% | 1.88% | 4.86% | -4.51% | |
68 Neutral | $56.17B | 20.85 | 22.26% | 2.51% | -3.82% | -15.29% | |
63 Neutral | $54.70B | 8.81 | 24.04% | 4.79% | -2.16% | -12.66% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | $23.55B | ― | 20.07% | ― | -39.27% | -182.36% |